Industry: Service & Software
Published Date: 2026-03-05
Pages: 171 Pages
Report ld: 5552751
Request Sample
Customized Report
Artificial Intelligence Diagnostics Market Size(US$)

CAGR 2026-2032
20.9%
Market Size,2032
USD 27,456
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Artificial Intelligence Diagnostics market was valued at US$ 7259 million in 2025 and is anticipated to reach US$ 27456 million by 2032, at a CAGR of 20.9% from 2026 to 2032.
Artificial Intelligence Diagnostics refers to regulated software systems that apply machine learning, deep learning, and advanced analytics to clinical data in order to support or deliver diagnostic decisions. Unlike general clinical analytics, AI diagnostics are designed to influence medical judgment by identifying disease, assessing severity, or recommending diagnostic conclusions based on inputs such as medical imaging, physiological signals (e.g., ECG, EEG), ophthalmic images, laboratory patterns, and multi-modal clinical data. Most solutions are commercialized as Software as a Medical Device (SaMD) and operate under strict regulatory frameworks such as FDA clearance or CE marking. AI diagnostics do not replace physicians but function as decision-support or physician-in-the-loop systems, improving diagnostic accuracy, speed, and consistency across healthcare settings.
Artificial Intelligence Diagnostics refers to regulated software systems that apply machine learning, deep learning, and advanced analytics to
The market can be classified by diagnostic data type (imaging-based, physiological signal-based, ophthalmic, multi-modal), by diagnostic role (screening, diagnostic assistance, automated diagnosis, severity assessment, therapy guidance), by clinical specialty (radiology, cardiology, neurology, ophthalmology, oncology, primary care), by deployment model (standalone SaMD, cloud SaaS, device-embedded, edge or wearable-based), and by regulatory/commercial type (FDA/CE-cleared diagnostic AI, clinical decision support, screening-only solutions).
Upstream players include medical device OEMs, sensor and imaging hardware suppliers, cloud and GPU infrastructure providers, and healthcare institutions contributing annotated clinical datasets. Midstream consists of AI diagnostics developers responsible for algorithm design, clinical validation, regulatory approval, and system integration with hospital IT. Downstream customers are hospitals, diagnostic centers, physician groups, and population-health programs, purchasing AI diagnostics through enterprise software contracts, bundled device sales, or subscription platforms.
Key costs arise from data acquisition and labeling, clinical trials, regulatory compliance, and continuous model maintenance. Due to software-driven economics, gross margins typically range from 65% to 80%. Transactions are dominated by subscription SaaS, per-use pricing, and multi-year enterprise licenses, increasingly bundled with devices or workflow platforms. Market trends include rapid expansion beyond radiology into cardiology and primary care, accelerated regulatory approvals, consolidation through M&A, and rising adoption driven by clinician shortages and value-based care models.
This report delivers a comprehensive overview of the global Artificial Intelligence Diagnostics market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Artificial Intelligence Diagnostics. The Artificial Intelligence Diagnostics market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Artificial Intelligence Diagnostics market comprehensively. Regional market sizes by Type, by Application, by Diagnostic Data Type, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Artificial Intelligence Diagnostics manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Diagnostic Data Type, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Artificial Intelligence Diagnostics companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Artificial Intelligence Diagnostics Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Services
1.2.3 Software
1.2.4 Hardware
1.3 Market by Diagnostic Data Type
1.3.1 Global Artificial Intelligence Diagnostics Market Size Growth Rate by Diagnostic Data Type: 2021 vs 2025 vs 2032
1.3.2 Medical Imaging–based
1.3.3 Physiological Signals–based
1.3.4 Ophthalmic Imaging–based
1.3.5 Others
1.4 Market by Deployment & Delivery
1.4.1 Global Artificial Intelligence Diagnostics Market Size Growth Rate by Deployment & Delivery: 2021 vs 2025 vs 2032
1.4.2 On-prem
1.4.3 Cloud SaaS
1.4.4 Edge / Embedded
1.4.5 Hybrid
1.4.6 Others
1.5 Market by Application
1.5.1 Global Artificial Intelligence Diagnostics Market Growth by Application: 2021 vs 2025 vs 2032
1.5.2 Radiology
1.5.3 Oncology
1.5.4 Neurology
1.5.5 Cardiology
1.5.6 Chest & Lungs
1.5.7 Others
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global Artificial Intelligence Diagnostics Market Perspective (2021–2032)
2.2 Global Artificial Intelligence Diagnostics Growth Trends by Region
2.2.1 Global Artificial Intelligence Diagnostics Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Artificial Intelligence Diagnostics Historic Market Size by Region (2021–2026)
2.2.3 Artificial Intelligence Diagnostics Forecasted Market Size by Region (2027–2032)
2.3 Artificial Intelligence Diagnostics Market Dynamics
2.3.1 Artificial Intelligence Diagnostics Industry Trends
2.3.2 Artificial Intelligence Diagnostics Market Drivers
2.3.3 Artificial Intelligence Diagnostics Market Challenges
2.3.4 Artificial Intelligence Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Artificial Intelligence Diagnostics Players by Revenue
3.1.1 Global Top Artificial Intelligence Diagnostics Players by Revenue (2021–2026)
3.1.2 Global Artificial Intelligence Diagnostics Revenue Market Share by Players (2021–2026)
3.2 Global Top Artificial Intelligence Diagnostics Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Artificial Intelligence Diagnostics Revenue
3.4 Global Artificial Intelligence Diagnostics Market Concentration Ratio
3.4.1 Global Artificial Intelligence Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Artificial Intelligence Diagnostics Revenue in 2025
3.5 Global Key Players of Artificial Intelligence Diagnostics Head Offices and Areas Served
3.6 Global Key Players of Artificial Intelligence Diagnostics, Products and Applications
3.7 Global Key Players of Artificial Intelligence Diagnostics, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Artificial Intelligence Diagnostics Breakdown Data by Type
4.1 Global Artificial Intelligence Diagnostics Historic Market Size by Type (2021–2026)
4.2 Global Artificial Intelligence Diagnostics Forecasted Market Size by Type (2027–2032)
5 Artificial Intelligence Diagnostics Breakdown Data by Application
5.1 Global Artificial Intelligence Diagnostics Historic Market Size by Application (2021–2026)
5.2 Global Artificial Intelligence Diagnostics Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Artificial Intelligence Diagnostics Market Size (2021–2032)
6.2 North America Artificial Intelligence Diagnostics Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Artificial Intelligence Diagnostics Market Size by Country (2021–2026)
6.4 North America Artificial Intelligence Diagnostics Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Artificial Intelligence Diagnostics Market Size (2021–2032)
7.2 Europe Artificial Intelligence Diagnostics Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Artificial Intelligence Diagnostics Market Size by Country (2021–2026)
7.4 Europe Artificial Intelligence Diagnostics Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Artificial Intelligence Diagnostics Market Size (2021–2032)
8.2 Asia-Pacific Artificial Intelligence Diagnostics Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Artificial Intelligence Diagnostics Market Size by Region (2021–2026)
8.4 Asia-Pacific Artificial Intelligence Diagnostics Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Artificial Intelligence Diagnostics Market Size (2021–2032)
9.2 Latin America Artificial Intelligence Diagnostics Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Artificial Intelligence Diagnostics Market Size by Country (2021–2026)
9.4 Latin America Artificial Intelligence Diagnostics Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Artificial Intelligence Diagnostics Market Size (2021–2032)
10.2 Middle East & Africa Artificial Intelligence Diagnostics Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Artificial Intelligence Diagnostics Market Size by Country (2021–2026)
10.4 Middle East & Africa Artificial Intelligence Diagnostics Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Butterfly Network
11.1.1 Butterfly Network Company Details
11.1.2 Butterfly Network Business Overview
11.1.3 Butterfly Network Artificial Intelligence Diagnostics Introduction
11.1.4 Butterfly Network Revenue in Artificial Intelligence Diagnostics Business (2021–2026)
11.1.5 Butterfly Network Recent Development
11.2 Merative
11.2.1 Merative Company Details
11.2.2 Merative Business Overview
11.2.3 Merative Artificial Intelligence Diagnostics Introduction
11.2.4 Merative Revenue in Artificial Intelligence Diagnostics Business (2021–2026)
11.2.5 Merative Recent Development
11.3 Tempus
11.3.1 Tempus Company Details
11.3.2 Tempus Business Overview
11.3.3 Tempus Artificial Intelligence Diagnostics Introduction
11.3.4 Tempus Revenue in Artificial Intelligence Diagnostics Business (2021–2026)
11.3.5 Tempus Recent Development
11.4 RetinAi
11.4.1 RetinAi Company Details
11.4.2 RetinAi Business Overview
11.4.3 RetinAi Artificial Intelligence Diagnostics Introduction
11.4.4 RetinAi Revenue in Artificial Intelligence Diagnostics Business (2021–2026)
11.4.5 RetinAi Recent Development
11.5 Nanox
11.5.1 Nanox Company Details
11.5.2 Nanox Business Overview
11.5.3 Nanox Artificial Intelligence Diagnostics Introduction
11.5.4 Nanox Revenue in Artificial Intelligence Diagnostics Business (2021–2026)
11.5.5 Nanox Recent Development
11.6 Lunit
11.6.1 Lunit Company Details
11.6.2 Lunit Business Overview
11.6.3 Lunit Artificial Intelligence Diagnostics Introduction
11.6.4 Lunit Revenue in Artificial Intelligence Diagnostics Business (2021–2026)
11.6.5 Lunit Recent Development
11.7 DiA Imaging
11.7.1 DiA Imaging Company Details
11.7.2 DiA Imaging Business Overview
11.7.3 DiA Imaging Artificial Intelligence Diagnostics Introduction
11.7.4 DiA Imaging Revenue in Artificial Intelligence Diagnostics Business (2021–2026)
11.7.5 DiA Imaging Recent Development
11.8 Subtle Medical
11.8.1 Subtle Medical Company Details
11.8.2 Subtle Medical Business Overview
11.8.3 Subtle Medical Artificial Intelligence Diagnostics Introduction
11.8.4 Subtle Medical Revenue in Artificial Intelligence Diagnostics Business (2021–2026)
11.8.5 Subtle Medical Recent Development
11.9 BrainMiner
11.9.1 BrainMiner Company Details
11.9.2 BrainMiner Business Overview
11.9.3 BrainMiner Artificial Intelligence Diagnostics Introduction
11.9.4 BrainMiner Revenue in Artificial Intelligence Diagnostics Business (2021–2026)
11.9.5 BrainMiner Recent Development
11.10 GE
11.10.1 GE Company Details
11.10.2 GE Business Overview
11.10.3 GE Artificial Intelligence Diagnostics Introduction
11.10.4 GE Revenue in Artificial Intelligence Diagnostics Business (2021–2026)
11.10.5 GE Recent Development
11.11 Siemens
11.11.1 Siemens Company Details
11.11.2 Siemens Business Overview
11.11.3 Siemens Artificial Intelligence Diagnostics Introduction
11.11.4 Siemens Revenue in Artificial Intelligence Diagnostics Business (2021–2026)
11.11.5 Siemens Recent Development
11.12 Aidoc
11.12.1 Aidoc Company Details
11.12.2 Aidoc Business Overview
11.12.3 Aidoc Artificial Intelligence Diagnostics Introduction
11.12.4 Aidoc Revenue in Artificial Intelligence Diagnostics Business (2021–2026)
11.12.5 Aidoc Recent Development
11.13 Imagen Technologies, Inc.
11.13.1 Imagen Technologies, Inc. Company Details
11.13.2 Imagen Technologies, Inc. Business Overview
11.13.3 Imagen Technologies, Inc. Artificial Intelligence Diagnostics Introduction
11.13.4 Imagen Technologies, Inc. Revenue in Artificial Intelligence Diagnostics Business (2021–2026)
11.13.5 Imagen Technologies, Inc. Recent Development
11.14 VUNO, Inc.
11.14.1 VUNO, Inc. Company Details
11.14.2 VUNO, Inc. Business Overview
11.14.3 VUNO, Inc. Artificial Intelligence Diagnostics Introduction
11.14.4 VUNO, Inc. Revenue in Artificial Intelligence Diagnostics Business (2021–2026)
11.14.5 VUNO, Inc. Recent Development
11.15 Digital Diagnostics
11.15.1 Digital Diagnostics Company Details
11.15.2 Digital Diagnostics Business Overview
11.15.3 Digital Diagnostics Artificial Intelligence Diagnostics Introduction
11.15.4 Digital Diagnostics Revenue in Artificial Intelligence Diagnostics Business (2021–2026)
11.15.5 Digital Diagnostics Recent Development
11.16 NeuraSignal
11.16.1 NeuraSignal Company Details
11.16.2 NeuraSignal Business Overview
11.16.3 NeuraSignal Artificial Intelligence Diagnostics Introduction
11.16.4 NeuraSignal Revenue in Artificial Intelligence Diagnostics Business (2021–2026)
11.16.5 NeuraSignal Recent Development
11.17 Riverain Technologies, LLC
11.17.1 Riverain Technologies, LLC Company Details
11.17.2 Riverain Technologies, LLC Business Overview
11.17.3 Riverain Technologies, LLC Artificial Intelligence Diagnostics Introduction
11.17.4 Riverain Technologies, LLC Revenue in Artificial Intelligence Diagnostics Business (2021–2026)
11.17.5 Riverain Technologies, LLC Recent Development
11.18 Philips
11.18.1 Philips Company Details
11.18.2 Philips Business Overview
11.18.3 Philips Artificial Intelligence Diagnostics Introduction
11.18.4 Philips Revenue in Artificial Intelligence Diagnostics Business (2021–2026)
11.18.5 Philips Recent Development
11.19 Microsoft
11.19.1 Microsoft Company Details
11.19.2 Microsoft Business Overview
11.19.3 Microsoft Artificial Intelligence Diagnostics Introduction
11.19.4 Microsoft Revenue in Artificial Intelligence Diagnostics Business (2021–2026)
11.19.5 Microsoft Recent Development
11.20 Viz.ai
11.20.1 Viz.ai Company Details
11.20.2 Viz.ai Business Overview
11.20.3 Viz.ai Artificial Intelligence Diagnostics Introduction
11.20.4 Viz.ai Revenue in Artificial Intelligence Diagnostics Business (2021–2026)
11.20.5 Viz.ai Recent Development
11.21 RapidAI
11.21.1 RapidAI Company Details
11.21.2 RapidAI Business Overview
11.21.3 RapidAI Artificial Intelligence Diagnostics Introduction
11.21.4 RapidAI Revenue in Artificial Intelligence Diagnostics Business (2021–2026)
11.21.5 RapidAI Recent Development
11.22 Canon Medical
11.22.1 Canon Medical Company Details
11.22.2 Canon Medical Business Overview
11.22.3 Canon Medical Artificial Intelligence Diagnostics Introduction
11.22.4 Canon Medical Revenue in Artificial Intelligence Diagnostics Business (2021–2026)
11.22.5 Canon Medical Recent Development
11.23 Enlitic
11.23.1 Enlitic Company Details
11.23.2 Enlitic Business Overview
11.23.3 Enlitic Artificial Intelligence Diagnostics Introduction
11.23.4 Enlitic Revenue in Artificial Intelligence Diagnostics Business (2021–2026)
11.23.5 Enlitic Recent Development
11.24 BioMind
11.24.1 BioMind Company Details
11.24.2 BioMind Business Overview
11.24.3 BioMind Artificial Intelligence Diagnostics Introduction
11.24.4 BioMind Revenue in Artificial Intelligence Diagnostics Business (2021–2026)
11.24.5 BioMind Recent Development
11.25 ANNALISE-AI PTY LTD
11.25.1 ANNALISE-AI PTY LTD Company Details
11.25.2 ANNALISE-AI PTY LTD Business Overview
11.25.3 ANNALISE-AI PTY LTD Artificial Intelligence Diagnostics Introduction
11.25.4 ANNALISE-AI PTY LTD Revenue in Artificial Intelligence Diagnostics Business (2021–2026)
11.25.5 ANNALISE-AI PTY LTD Recent Development
11.26 icometrix
11.26.1 icometrix Company Details
11.26.2 icometrix Business Overview
11.26.3 icometrix Artificial Intelligence Diagnostics Introduction
11.26.4 icometrix Revenue in Artificial Intelligence Diagnostics Business (2021–2026)
11.26.5 icometrix Recent Development
11.27 KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO)
11.27.1 KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO) Company Details
11.27.2 KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO) Business Overview
11.27.3 KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO) Artificial Intelligence Diagnostics Introduction
11.27.4 KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO) Revenue in Artificial Intelligence Diagnostics Business (2021–2026)
11.27.5 KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Artificial Intelligence Diagnostics market is projected to grow from US$ 7259 million in 2025 to US$ 27456 million by 2032, at a CAGR of 20.9% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-09
Pages: 187
USD 4900.00
(Single User License)
The global Artificial Intelligence Diagnostics market size was US$ 7259 million in 2025 and is forecast to reach a readjusted size of US$ 27456 million by 2032 with a CAGR of 20.9% during the forecast period 2026-2032.
Published Date: 2026-03-09
Pages: 128
USD 4250.00
(Single User License)
The global market for Artificial Intelligence Diagnostics was estimated to be worth US$ 7259 million in 2025 and is projected to reach US$ 27456 million, growing at a CAGR of 20.9% from 2026 to 2032.
Published Date: 2026-03-05
Pages: 161
USD 3950.00
(Single User License)
The global Artificial Intelligence Diagnostics market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-23
Pages: 144
USD 4900.00
(Single User License)
The global Artificial Intelligence Diagnostics market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 94
USD 4250.00
(Single User License)
The global market for Artificial Intelligence Diagnostics was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 116
USD 3950.00
(Single User License)
The global market for Artificial Intelligence Diagnostics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-20
Pages: 88
USD 2900.00
(Single User License)
AI in Diagnostics is mainly focusing on solving patient safety issues caused by known problems with diagnostic testing. Many diagnostic issues are data-driven and resolving them requires new data-science based approaches. AI in Diagnostics is focusing on using innovative AI and machine-learning to improve diagnostic accuracy and cut costs – improving patient safety worldwide.
Published Date: 2024-04-07
Pages: 106
USD 4900.00
(Single User License)
AI in Diagnostics is mainly focusing on solving patient safety issues caused by known problems with diagnostic testing. Many diagnostic issues are data-driven and resolving them requires new data-science based approaches. AI in Diagnostics is focusing on using innovative AI and machine-learning to improve diagnostic accuracy and cut costs – improving patient safety worldwide.
Published Date: 2024-02-19
Pages: 102
USD 3950.00
(Single User License)
AI in Diagnostics is mainly focusing on solving patient safety issues caused by known problems with diagnostic testing. Many diagnostic issues are data-driven and resolving them requires new data-science based approaches. AI in Diagnostics is focusing on using innovative AI and machine-learning to improve diagnostic accuracy and cut costs – improving patient safety worldwide.
Published Date: 2024-02-07
Pages: 85
USD 2900.00
(Single User License)
The global Artificial Intelligence Diagnostics market is projected to grow from US$ 7259 million in 2025 to US$ 27456 million by 2032, at a CAGR of 20.9% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-09
Pages: 187
The global Artificial Intelligence Diagnostics market size was US$ 7259 million in 2025 and is forecast to reach a readjusted size of US$ 27456 million by 2032 with a CAGR of 20.9% during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 128
The global market for Artificial Intelligence Diagnostics was estimated to be worth US$ 7259 million in 2025 and is projected to reach US$ 27456 million, growing at a CAGR of 20.9% from 2026 to 2032.
Published: 2026-03-05
Pages: 161
The global Artificial Intelligence Diagnostics market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-23
Pages: 144
The global Artificial Intelligence Diagnostics market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 94
The global market for Artificial Intelligence Diagnostics was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 116
The global market for Artificial Intelligence Diagnostics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-20
Pages: 88
AI in Diagnostics is mainly focusing on solving patient safety issues caused by known problems with diagnostic testing. Many diagnostic issues are data-driven and resolving them requires new data-science based approaches. AI in Diagnostics is focusing on using innovative AI and machine-learning to improve diagnostic accuracy and cut costs – improving patient safety worldwide.
Published: 2024-04-07
Pages: 106
AI in Diagnostics is mainly focusing on solving patient safety issues caused by known problems with diagnostic testing. Many diagnostic issues are data-driven and resolving them requires new data-science based approaches. AI in Diagnostics is focusing on using innovative AI and machine-learning to improve diagnostic accuracy and cut costs – improving patient safety worldwide.
Published: 2024-02-19
Pages: 102
AI in Diagnostics is mainly focusing on solving patient safety issues caused by known problems with diagnostic testing. Many diagnostic issues are data-driven and resolving them requires new data-science based approaches. AI in Diagnostics is focusing on using innovative AI and machine-learning to improve diagnostic accuracy and cut costs – improving patient safety worldwide.
Published: 2024-02-07
Pages: 85
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now